S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
Stock market today: Asian shares are mostly higher after another set of Wall St records
3 Value Stocks Too Small For Buffett’s Portfolio
Disney Stock Catches 3 Upgrades In a Single Week
Walgreens Boots Alliance: Deep Value With Nowhere to Go But Up
Foot Locker Builds Up Another Head of Steam; Gains Imminent
Average long-term US mortgage rate falls slightly, easing borrowing costs for home shoppers
Walgreens books hefty charge as the drugstore chain adjusts the value of struggling clinics
S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
Stock market today: Asian shares are mostly higher after another set of Wall St records
3 Value Stocks Too Small For Buffett’s Portfolio
Disney Stock Catches 3 Upgrades In a Single Week
Walgreens Boots Alliance: Deep Value With Nowhere to Go But Up
Foot Locker Builds Up Another Head of Steam; Gains Imminent
Average long-term US mortgage rate falls slightly, easing borrowing costs for home shoppers
Walgreens books hefty charge as the drugstore chain adjusts the value of struggling clinics
S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
Stock market today: Asian shares are mostly higher after another set of Wall St records
3 Value Stocks Too Small For Buffett’s Portfolio
Disney Stock Catches 3 Upgrades In a Single Week
Walgreens Boots Alliance: Deep Value With Nowhere to Go But Up
Foot Locker Builds Up Another Head of Steam; Gains Imminent
Average long-term US mortgage rate falls slightly, easing borrowing costs for home shoppers
Walgreens books hefty charge as the drugstore chain adjusts the value of struggling clinics
S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
Stock market today: Asian shares are mostly higher after another set of Wall St records
3 Value Stocks Too Small For Buffett’s Portfolio
Disney Stock Catches 3 Upgrades In a Single Week
Walgreens Boots Alliance: Deep Value With Nowhere to Go But Up
Foot Locker Builds Up Another Head of Steam; Gains Imminent
Average long-term US mortgage rate falls slightly, easing borrowing costs for home shoppers
Walgreens books hefty charge as the drugstore chain adjusts the value of struggling clinics
NASDAQ:LGVN

Longeveron (LGVN) Stock Price, News & Analysis

$3.25
+0.14 (+4.50%)
(As of 03/28/2024 ET)
Today's Range
$3.20
$3.64
50-Day Range
$3.13
$9.50
52-Week Range
$2.92
$44.00
Volume
154,047 shs
Average Volume
22,137 shs
Market Capitalization
$8.16 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$60.00

Longeveron MarketRank™ Stock Analysis

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
1,746.2% Upside
$60.00 Price Target
Short Interest
Healthy
0.17% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.93mentions of Longeveron in the last 14 days
Based on 5 Articles This Week
Insider Trading
Acquiring Shares
$6,550 Bought Last Quarter
Proj. Earnings Growth
N/A

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

3.30 out of 5 stars

LGVN stock logo

About Longeveron Stock (NASDAQ:LGVN)

Longeveron Inc., a clinical stage biotechnology company, develops cellular therapies for aging-related and life-threatening conditions in the United States and Japan. The company's lead investigational product is the LOMECEL-B, an allogeneic mesenchymal stem cell formulation sourced from the bone marrow of young, healthy adult donors. It is conducting Phase 1, Phase 2a, and Phase 2b clinical trials in various indications, such as aging-related frailty, alzheimer's disease, and hypoplastic left heart syndrome. The company was incorporated in 2014 and is headquartered in Miami, Florida.

LGVN Stock Price History

LGVN Stock News Headlines

Longeveron Announces 1-for-10 Reverse Stock Split
Claim Your Complimentary Bitcoin Reward
Many have already secured their free Bitcoin reward offered by our esteemed guest. How about you? In an effort to spread the word about our upcoming workshop, he's generously offering $10 in Bitcoin (BTC) to participants. Absolutely no strings attached.
Longeveron Inc. (LGVN) Q4 2023 Earnings Call Transcript
Recap: Longeveron Q4 Earnings
Trump’s “Tax Free” Retirement Strategy
Since 1924 — over one hundred years — the US dollar has lost nearly 18x its value. In other words, a dollar back then would buy $17.82 worth of goods in today's money. If you're planning on retiring any time soon…This poses a real problem.
LGVN Continues to Show Progress
See More Headlines
Receive LGVN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Longeveron and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
2/27/2024
Today
3/28/2024
Next Earnings (Estimated)
5/10/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:LGVN
Fax
N/A
Employees
23
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$60.00
High Stock Price Target
$60.00
Low Stock Price Target
$60.00
Potential Upside/Downside
+1,746.2%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
1 Analysts

Profitability

Net Income
$-21,410,000.00
Net Margins
-3,020.17%
Pretax Margin
-3,020.17%

Debt

Sales & Book Value

Annual Sales
$709,000.00
Book Value
$0.27 per share

Miscellaneous

Free Float
19,017,000
Market Cap
$8.17 million
Optionable
Not Optionable
Beta
0.32
Ten Starter Stocks For Beginners to Buy Now Cover

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report

Key Executives

  • Dr. Joshua Michael Hare FACC (Age 61)
    M.D., Co-Founder, Chief Science Officer & Chairman
    Comp: $74k
  • Mr. Mohamed Wa'el Ahmed Hashad (Age 62)
    CEO & Director
    Comp: $781.56k
  • Ms. Lisa A. Locklear M.B.A. (Age 62)
    Executive VP & CFO
    Comp: $248.38k
  • Mr. Paul T. Lehr J.D.Mr. Paul T. Lehr J.D. (Age 56)
    International Executive Director, General Counsel & Secretary
    Comp: $554.05k
  • Dr. Dan Gincel Ph.D. (Age 53)
    Senior Vice President of Strategic Collaborations & Scientific Affairs
  • Dr. Nataliya Agafanova M.D. (Age 54)
    Chief Medical Officer
  • Ms. Elly Ryu (Age 42)
    VP & Corporate Controller

LGVN Stock Analysis - Frequently Asked Questions

Should I buy or sell Longeveron stock right now?

1 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Longeveron in the last year. There are currently 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" LGVN shares.
View LGVN analyst ratings
or view top-rated stocks.

What is Longeveron's stock price target for 2024?

1 Wall Street analysts have issued 12 month price objectives for Longeveron's stock. Their LGVN share price targets range from $60.00 to $60.00. On average, they anticipate the company's share price to reach $60.00 in the next year. This suggests a possible upside of 1,746.2% from the stock's current price.
View analysts price targets for LGVN
or view top-rated stocks among Wall Street analysts.

How have LGVN shares performed in 2024?

Longeveron's stock was trading at $13.60 on January 1st, 2024. Since then, LGVN stock has decreased by 76.1% and is now trading at $3.25.
View the best growth stocks for 2024 here
.

Are investors shorting Longeveron?

Longeveron saw a drop in short interest in March. As of March 15th, there was short interest totaling 15,400 shares, a drop of 92.0% from the February 29th total of 192,900 shares. Based on an average daily volume of 29,800 shares, the days-to-cover ratio is presently 0.5 days. Currently, 0.2% of the company's shares are short sold.
View Longeveron's Short Interest
.

When is Longeveron's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Friday, May 10th 2024.
View our LGVN earnings forecast
.

How were Longeveron's earnings last quarter?

Longeveron Inc. (NASDAQ:LGVN) released its earnings results on Tuesday, February, 27th. The company reported ($2.50) EPS for the quarter, missing analysts' consensus estimates of ($2.10) by $0.40. The company had revenue of $0.06 million for the quarter, compared to analysts' expectations of $0.21 million. Longeveron had a negative net margin of 3,020.17% and a negative trailing twelve-month return on equity of 209.14%.

When did Longeveron's stock split?

Shares of Longeveron reverse split on the morning of Wednesday, March 27th 2024. The 1-10 reverse split was announced on Wednesday, March 27th 2024. The number of shares owned by shareholders was adjusted after the closing bell on Wednesday, March 27th 2024. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split.

When did Longeveron IPO?

Longeveron (LGVN) raised $30 million in an IPO on Friday, February 12th 2021. The company issued 2,700,000 shares at a price of $10.00-$12.00 per share. Kingswood Capital Markets and Alexander Capital L.P. acted as the underwriters for the IPO.

Who are Longeveron's major shareholders?

Longeveron's stock is owned by a number of institutional and retail investors. Top institutional investors include Armistice Capital LLC (7.31%), Northern Trust Corp (0.20%) and Citadel Advisors LLC (0.13%). Insiders that own company stock include Cathy Ross, Geoff Green, James Clavijo, Jeffrey Pfeffer, Joshua Hare, Paul T Lehr and Rock Soffer.
View institutional ownership trends
.

How do I buy shares of Longeveron?

Shares of LGVN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:LGVN) was last updated on 3/29/2024 by MarketBeat.com Staff

From Our Partners